Endocrine News - The Leading Magazine for Endocrinologists

Veiled Threats: New Findings Show More Links Between EDCs and Cardiovascular Health

As heart disease continues to kill more Americans than any other ailment annually, more endocrine research is linking endocrine disruptors to cardiovascular health. Despite a lack of significant action to reduce EDCs, patients can reduce their own exposure to these compounds. Cardiovascular disease (CVD) is the leading cause of mortality in the U.S., responsible for...

CEU Preview

Asked & Answered: The Virtual Reality of CEU & EBR 2020

Endocrine News talks to Endocrine Board Review committee chair Serge Jabbour, MD, FACP, FACE, and Clinical Endocrinology Update committee chair Marc-Andre Cornier, MD, to find out what participants can expect from this year’s virtual offerings and why they are definitely the must-see events they’ve always been. Every year, the Endocrine Society holds the Clinical Endocrinology...

Bone Health Experts Issue Osteoporosis Treatment Guidance During COVID-19

As the COVID-19 pandemic became more serious, the Endocrine Society joined a coalition of bone health organizations that united to issue new osteoporosis treatment guidelines. Aside from addressing the challenges social distancing has placed on treating these patients, the coalition has also focused on the administration of osteoporosis medications including denosumab, teriparatide, abaloparatide, romosozumab, and...

CEU Preview

All in the Timing: Osteoporosis Medications

Michael Lewiecki, MD, will detail the importance of when to time treatments for patients with osteoporosis to reduce fractures, as well as the concepts of imminent fracture risk, treat-to-target, and sequence of therapy in his CEU session “Osteoporosis Medication: Timing Is Everything.” Timing is everything. That’s true about a lot of things in life –...

Next-Generation Integrated Continuous Glucose Monitor Now Available Following FDA Clearance

An integrated continuous glucose monitor (iCGM) is now available for adults and now children (4+ years) living with diabetes, following its clearance in June from the U.S. Food and Drug Administration (FDA). Abbot is marketing this new technology as the FreeStyle® Libre 2. The FreeStyle Libre 2 system uses Bluetooth to automatically alerts users when...

Up, Up, and Away: How Drones Could Revolutionize Insulin Delivery

Drones have delivered medications and other medical supplies to people in underdeveloped areas, but what of their use in times of disaster or even a pandemic to patients with chronic conditions such as diabetes? A multidisciplinary team has taken the first step to achieving insulin delivery via drone. The Aran Islands, located about 12 miles...

New Trial Data Show Positive Results for Treating Thyroid Eye Disease

Two clinical trials have shown positive topline data that add to the growing body of evidence supporting the efficacy and safety of teprotumumab-trbw for the treatment of Thyroid Eye Disease (TED). Horizon Therapeutics is marketing the drug as TEPEZZA, the first medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of...

Diabetes News and Research

Long-Term Culture of Human Pancreatic Slices Reveals the Regeneration of Insulin-Producing Cells in Real Time

Scientists from the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine have developed a method allowing for the long-term culture of “pancreatic slices” to study the regeneration of the human pancreas in real time. The results, published recently in Nature Communications, demonstrate that extended cultures of near-intact human pancreatic tissue...

Endocrine news on twitter